Corroborating the results obtained with the animal models of NASH, expression of miR-21 in the liver of NAFLD patients significantly increased from steatosis to NASH (P<0.01; Figure 6a), with a concomitant decrease in PPARα expression (P<0.01; Figure 6b). Here, PPARA is linked to metabolic dysfunction-associated steatotic liver disease.